A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Screening of Inhibitors Targeting Heat Shock Protein 47 Involved in the Development of Idiopathic Pulmonary Fibrosis. | LitMetric

AI Article Synopsis

  • - Heat shock protein 47 (HSP47) is linked to fibrotic diseases and finding compounds that disrupt its interaction with collagen is crucial for developing new treatments.
  • - Researchers created a system to test potential HSP47 inhibitors by expressing it as a soluble protein in E. coli and screened over 1000 compounds from a library at Nagasaki University.
  • - Out of the screened compounds, 13 showed inhibitory effects, with epigallocatechin-3-O-gallate (a polyphenol from tea) being one of the most effective, indicating that specific structural features are important for its activity against HSP47.

Article Abstract

Heat shock protein 47 (HSP47), a collagen-specific molecular chaperone, is causally related to fibrotic diseases, including idiopathic pulmonary fibrosis. The identification of Compounds that interfere with the HSP47-collagen interaction is essential for the development of relevant therapeutics. Herein, we prepared human HSP47 as a soluble fusion protein expressed in E. coli and established an assay system for HSP47 inhibitor screening. We screened a natural and synthetic Compound library established at Nagasaki University. Among 1023 Compounds, 13 exhibited inhibitory activity against human HSP47, of which three inhibited its function in a dose-dependent manner. Epigallocatechin-3-O-gallate, one of these three Compounds, is a typical polyphenol Compound derived from tea leaves. Structurally related Compounds were synthesized and examined for their activity, revealing a hydroxyl group at A-ring position 5 as important for its activity. The present findings provide valuable insight for the development of natural product-derived therapeutics for fibrotic diseases, including idiopathic pulmonary fibrosis.

Download full-text PDF

Source
http://dx.doi.org/10.1002/cmdc.202100064DOI Listing

Publication Analysis

Top Keywords

idiopathic pulmonary
12
pulmonary fibrosis
12
heat shock
8
shock protein
8
fibrotic diseases
8
diseases including
8
including idiopathic
8
human hsp47
8
screening inhibitors
4
inhibitors targeting
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!